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To The Editor: Monomicrobial 
liver abscesses caused by Klebsiella 
pneumoniae are an emerging problem 
in Asia. Among 77 capsular types of 
Klebsiella spp., K1 and K2 are the 
most virulent (1–3). In Asia, isolated 
strains are mainly serotype K1, fol-
lowed by K2. In Taiwan, about 63.4% 
of liver abscesses caused by K. pneu-
moniae are associated with K1 strains 
and 14.2% by K2 (4); no comparable 
epidemioogic data for Western coun-
tries are available (5,6). Cases of K. 
pneumoniae liver abscesses have been 
also reported from North America 
and Europe (6–9); patients outside of 
Asia predominantly have a history of 
traveling to high-prevalence countries 
and/or Asian ethnicity (10). 
We describe 2 cases of K. pneu-
moniae liver abscesses in patients in 
Germany. Both cases were associ-
ated with life-threatening metastatic 
spread of K. pneumoniae in previ-
ously healthy white patients with no 
travel history, no Asian ethnicity, and 
no contact with persons in high-risk 
groups, including patients with K. 
pneumoniae infection.
Patient 1 was a 48-year-old white 
male medical doctor with no history of 
serious medical conditions, who sud-
denly experienced fever up to 40°C, 
abdominal pain, mild diarrhea, and 
fatigue. Blood analysis revealed signs 
of inflammation: C-reactive protein 
level of 26 mg/dL.  Erythrocyte and 
leukocyte counts were within refer-
ence ranges, but thrombocytes were 
decreased (43,000 cells/mL) and liver 
enzymes were increased (glutamate 
pyruvate transaminase 112 U/L, as-
partate aminotransferase 75 U/L, gam-
ma glutamyl transferase 332 U/L). An 
initial chest radiograph and abdominal 
ultrasonograms were unremarkable. 
K. pneumoniae was isolated from 
blood and urine and was later charac-
terized as K1 capsular type (no further 
typing techniques could be performed 
because no sample was stored). Cef-
triaxone was administered, in accor-
dance with an antibiogram, but the 
patient’s condition worsened and he 
required mechanical ventilation and 
treatment with a catecholamine in an 
intensive care unit. A computed to-
mographic (CT) scan showed 2 liver 
abscesses and infiltrates of both lungs 
with pleural effusion (Figure). Under 
CT guidance, the liver abscesses were 
punctured and drained percutaneously 
by using pigtail catheters. After this 
intervention, the patient recovered 
gradually. The drain was removed af-
ter 10 days, and ceftriaxone treatment 
was continued for a total of 21 days. 
The patient recovered and was trans-
ferred to a rehabilitation hospital.
Patient 2 was a 71-year-old white 
woman with type-2 diabetes, who was 
hospitalized for epigastric pain and fa-
tigue. Laboratory results showed an 
increased level of C-reactive protein (13 
mg/dL), blood count and liver enzymes 
within reference range, and a urinary 
tract infection positive for nitrite and 
leukocytes (500/mL). Abdominal ultra-
sonography revealed a 3 × 4-cm subcap-
sular lesion in the left lobe of the liver, 
highly suspect for metastatic spread of 
an unknown tumor. Chest radiographs, 
taken in search of the primary lesion, 
revealed a lesion in the right upper 
lung; on follow-up CT images, this le-
sion was suspect for malignancy (Fig-
ure). For diagnostic purposes, the liver 
lesion was punctured and a sample was 
obtained. Histologic analysis revealed 
pus, which was in accordance with an 
abscess. A pigtail drain was placed, and 
K. pneumoniae was cultured from the 
liver punctate as well as from the urine. 
The isolate proved to be serotype K2. 
Multilocus sequencing of this strain 
confirmed the presence of the wzx2 
and wzy2 genes. In accordance with 
susceptibility test results, therapy with 
ceftriaxone and ciprofloxacin was initi-
ated. Dislocation of the pigtail catheter 
resulted in an abscess of the abdominal 
wall, which required additional surgical 
treatment. However, the patient recov-
ered within 2 weeks. Follow-up CT im-
ages showed resolution of the thoracic 
lesion and only a residual scar on the 
liver lobe (online Technical Appen-
dix http://wwwnc.cdc.gov/EID/article/ 
20/11/14-0149-Techapp1.pdf). 
These 2 cases of community-
acquired K. pneumoniae serotype K1 
and K2 liver abscesses with metastatic 






in previously healthy white patients 
from Germany differ from previous-
ly published cases. These 2 patients 
were not of Asian ethnicity and had no 
travel history, no contact with persons 
in a high-risk group (10), and no com-
mon risk factors such as malignancy 
(8); however, 1 patient had type-2 dia-
betes. K. pneumoniae liver abscesses 
might be an emerging problem with 
global spread. Although initial radio-
graphic findings might more common-
ly indicate metastasis than abscesses, 
differential diagnosis of liver lesions 
should include K. pneumoniae– 
induced abscesses. 
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Hepatitis E Virus 
and Implications  
for Blood Supply 
Safety, Australia
To the Editor: Hepatitis E virus 
(HEV) is an emerging public health 
concern for industrialized countries 
(1). Although HEV infection has been 
associated with travel to countries 
where the virus is endemic, cases of 
autochthonous HEV are increasing 
(2). Detection of HEV RNA in blood 
donations in the United Kingdom, 
Germany, the Netherlands, Japan, 
and China and accumulating reports 
of HEV transmitted through blood 
transfusion highlight the potential 
risk this virus poses to blood supply 
safety (1–4).
In Australia, where most HEV 
infections are associated with travel 
(5), an average of 25 HEV cases oc-
curred each year during 1999–2013 
(http://www9.health.gov.au/cda/
source/rpt_3.cfm). HEV infection is 
nationally notifiable in Australia, but 
the presence of subclinical infections 
and the lack of recent seroprevalence 
studies have prevented the accurate 
estimation of HEV incidence and pop-
ulation exposure. Thus, we examined 
HEV seroprevalence in a cohort of 
Australian blood donors, assessed risk 
factors for exposure, and used the data 
to examine the effectiveness of current 
blood safety strategies for the manage-
ment of HEV in Australia.
Plasma samples (n = 3,237) were 
collected from donors during August–
September 2013. Information on age, 
sex, state of residence, new/repeat do-
nor status, and overseas travel disclo-
sure was obtained. Details of any rele-
vant blood donation deferral (malaria, 
diarrhea) applied on previous donation 
attempts were also collected. Applica-
tion of a specific malaria deferral code 
is routine for donors disclosing travel 
to a malaria-endemic country, and a 
diarrhea deferral applies when a donor 
reports having had diarrhea (of viral or 
unknown cause) 1 week before any at-
tempted donation. 
All samples were tested for HEV 
IgG by using the Wantai HEV-IgG 
ELISA (Beijing Wantai Biologic Phar-
macy Enterprise Co., Ltd, Beijing, 
China). Positive samples were tested 
for HEV IgM by using the Wantai 
HEV-IgM ELISA and for HEV RNA 
by using a prototype transcription-
mediated amplification assay (Hologic 
Inc., San Diego, CA, USA).
Of 3,237 samples, 194 (5.99%) 
were positive for HEV IgG (95% CI 
5.18–6.81). Compared with estimates 
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